In last trading session, SELLAS Life Sciences Group Inc (NASDAQ:SLS) saw 9.47 million shares changing hands with its beta currently measuring 2.26. Company’s recent per share price level of $1.28 trading at $0.04 or 3.23% at ring of the bell on the day assigns it a market valuation of $72.03M. That closing price of SLS’s stock is at a discount of -49.22% from its 52-week high price of $1.91 and is indicating a premium of 60.94% from its 52-week low price of $0.50. Taking a look at company’s average trading volume volume of 1.48 million if we extend that period to 3-months.
SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information
Upright in the green during last session for gaining 3.23%, in the last five days SLS remained trading in the red while hitting it’s week-highest on Thursday, 04/25/24 when the stock touched $1.28 price level, adding 18.99% to its value on the day. SELLAS Life Sciences Group Inc’s shares saw a change of 20.75% in year-to-date performance and have moved -16.88% in past 5-day. SELLAS Life Sciences Group Inc (NASDAQ:SLS) showed a performance of 8.47% in past 30-days.
SELLAS Life Sciences Group Inc (SLS) estimates and forecasts
Statistics highlight that SELLAS Life Sciences Group Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 10.34% of value to its shares in past 6 months, showing an annual growth rate of 29.10% while that of industry is 12.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 55.30% in the current quarter and calculating 38.70% increase in the next quarter.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of -$ for the same. And 1 analysts are in estimates of company making revenue of -$ in the next quarter that will end on Jun 2024. Company posted -$ and -$ of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 61.44% during past 5 years.
SLS Dividends
SELLAS Life Sciences Group Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
